The objective of this proposal is to investigate the preventive role of soy isoflavones in prostate cancer (PCA) progression and angiogenesis.
The specific aims are: l) to study the effects of soy isoflavones on inhibiting expression of membrane-type metalloproteinase (MT-MMP) by PCA cells, fibroblasts, or endothelial cells (ECs) in vitro, and 2) to determine if diets containing soy protein isolate (SPI) or purified isoflavones inhibit prostate tumor progression, angiogenesis, and MT-MMP expression in vivo. Human PCA cells (PC-3, DU 145, and LNCAP), fibroblasts, and ECs will be treated with isoflavones. MMPs-containing conditioned media and MT-MMP-containing plasma membranes will be prepared. RNase protection assays, Western blotting, and zymography will be applied to determine mRNA, protein, and activity of MT-MMP to test the hypothesis that isoflavones inhibit PCA progression, and prostate tumor angiogenesis by inhibiting MT-MMP expression by PCA and fibroblasts, and ECs, respectively. In animal study, human PCA cell-inoculated nude mice will be fed control, SPI-based, or isoflavone-supplemented diets. Tumor sizes will be measured, and tumors removed for determinations of MT-MMP mRNA, protein and activity to evaluate the effects of isoflavones on in vivo inhibition of PCA progression. Anti-angiogenic effect of isoflavones will be evaluated by immunohistochemical analysis of microvessels.
Zhou, Jin-Rong; Yu, Lunyin; Zhong, Ying et al. (2002) Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components. Prostate 53:143-53 |
Mukherjee, P; Sotnikov, A V; Mangian, H J et al. (1999) Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. J Natl Cancer Inst 91:512-23 |
Zhou, J R; Gugger, E T; Tanaka, T et al. (1999) Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129:1628-35 |
Zhou, J R; Mukherjee, P; Gugger, E T et al. (1998) Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res 58:5231-8 |